[Federal Register: June 27, 2002 (Volume 67, Number 124)]
[Notices]               
[Page 43321-43322]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jn02-86]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-63]

 
Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To

[[Page 43322]]

request more information on the proposed projects or to obtain a copy 
of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Assisted Reproductive Technology (ART) Program 
Reporting System, (OMB No. 0920-0556)--Extension--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).
    Background: Section 2(a) of Pub. L. 102-493 (known as the Fertility 
Clinic Success Rate and Certification Act of 1992 (FCSRCA), 42 U.S.C. 
263a-1(a)) requires that each assisted reproductive technology (ART) 
program shall annually report to the Secretary through the Centers for 
Disease Control and Prevention--(1) pregnancy success rates achieved by 
such ART program, and (2) the identity of each embryo laboratory used 
by such ART program and whether the laboratory is certified or has 
applied for such certification under this act.
    The Centers for Disease Control and Prevention (CDC) is seeking to 
extend approval of a reporting system for Assisted Reproductive 
Technology (ART) Program from the Office of Management and Budget 
(OMB). This reporting system has been designed in collaboration with 
the Society for Assisted Reproductive Technology (SART) to comply with 
the requirements of the FCSRCA. The reporting system includes all ART 
cycles initiated by any of the approximately 400 ART programs in the 
United States, and covers the pregnancy outcome of each cycle, as well 
as a number of data items deemed important to explain variability in 
success rates across clinics and across individuals. Data is to be 
collected through computer software developed by SART in consultation 
with CDC.
    In developing the definition of pregnancy success rates and the 
list of data items to be reported, CDC has consulted with 
representatives of SART, the American Society for Reproductive 
Medicine, and RESOLVE, the National Infertility Association (a 
national, nonprofit consumer organization), as well as a variety of 
individuals with expertise and interest in this field. The average 
annual cost to the respondent, including data entry labor and fees, is 
estimated to be $2,140.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden/
                   Respondents                       Number of      responses/     response  (in   Total burden
                                                    respondents     respondent        hours)        (in hours)
----------------------------------------------------------------------------------------------------------------
ART Clinics.....................................             400             220            5/60           7,333
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............           7,333
----------------------------------------------------------------------------------------------------------------


    Dated: June 20, 2002.
Nancy E. Cheal,
Acting Deputy Director for Policy, Planning and Evaluation, Centers for 
Disease Control and Prevention.
[FR Doc. 02-16178 Filed 6-26-02; 8:45 am]
BILLING CODE 4163-18-P